Skip to content

A Multimodal MRI-Based Study on the Rapid Antidepressant Mechanisms of Acupuncture and Individualized Treatment Response Prediction in Depression

Antidepressant Mechanisms of Acupuncture and Individualized Treatment Response Prediction in Depression

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026001205
Enrollment
Unknown
Registered
2026-05-07
Start date
2026-05-15
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major depressive disorder

Interventions

Acupuncture group:Electroacupuncture Needle Stimulation at Acupoints Prescription
Sham acupuncture group:Acupuncture at non-meridian, non-acupoint sites, the electroacupuncture device does not output current.

Sponsors

Tsinghua University Yuquan Hospital (Tsinghua University Hospital of Integrated Traditional Chinese and Western Medicine)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 59 Years

Inclusion criteria

Inclusion criteria: 1.Aged 18 to 59 years, and right-handed; 2.Patients who have received systematic antidepressant treatment (including antidepressant medications, sedative-hypnotics, electroconvulsive therapy, or transcranial magnetic stimulation) within the 4 weeks prior to enrollment; 3.Having a total score on the 17-item Hamilton Depression Rating Scale (HAMD-17) greater than 7 and less than or equal to 24; 4.Voluntary participation in the study, with written informed consent provided by the patient themselves or their legally authorized guardian.

Exclusion criteria

Exclusion criteria: 1.Diagnosis of other major psychiatric disorders or presence of psychotic symptoms. 2.History of other severe somatic diseases (e.g., cardiovascular/cerebrovascular diseases, autoimmune diseases), or current/past neurological or organic brain diseases. 3.Current or past history of alcohol dependence or abuse of other psychoactive substances. 4.Women who are lactating, pregnant, or menstruating. 5.Patients who have participated in other clinical drug trials within the past 3 months.

Design outcomes

Primary

MeasureTime frame
Montgomery-Åsberg Depression Rating Scale;

Secondary

MeasureTime frame
Hamilton Depression Rating Scale;Positive and Negative Affect Schedule;Maudsley Three-Item Visual Analogue Scale;

Countries

China

Contacts

Public ContactFan Chunling

Tsinghua University Yuquan Hospital (Tsinghua University Hospital of Integrated Traditional Chinese and Western Medicine)

fanjingzi1@126.com18310619099

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Jun 11, 2026